These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 11755313)
21. Bortezomib alleviates drug-induced liver injury by regulating CYP2E1 gene transcription. Park WJ; Kim SY; Kim YR; Park JW Int J Mol Med; 2016 Mar; 37(3):613-22. PubMed ID: 26797017 [TBL] [Abstract][Full Text] [Related]
22. Brain CYP2E1 is induced by nicotine and ethanol in rat and is higher in smokers and alcoholics. Howard LA; Miksys S; Hoffmann E; Mash D; Tyndale RF Br J Pharmacol; 2003 Apr; 138(7):1376-86. PubMed ID: 12711639 [TBL] [Abstract][Full Text] [Related]
23. Multiple cardiac proteasome subtypes differ in their susceptibility to proteasome inhibitors. Kloss A; Meiners S; Ludwig A; Dahlmann B Cardiovasc Res; 2010 Jan; 85(2):367-75. PubMed ID: 19564153 [TBL] [Abstract][Full Text] [Related]
24. Low doses of nicotine and ethanol induce CYP2E1 and chlorzoxazone metabolism in rat liver. Howard LA; Micu AL; Sellers EM; Tyndale RF J Pharmacol Exp Ther; 2001 Nov; 299(2):542-50. PubMed ID: 11602665 [TBL] [Abstract][Full Text] [Related]
25. Enhancement of radiosensitivity by proteasome inhibition: implications for a role of NF-kappaB. Russo SM; Tepper JE; Baldwin AS; Liu R; Adams J; Elliott P; Cusack JC Int J Radiat Oncol Biol Phys; 2001 May; 50(1):183-93. PubMed ID: 11316563 [TBL] [Abstract][Full Text] [Related]
26. Effects of soy protein on alcoholic liver disease in rats undergoing ethanol withdrawal. Yang HY; Lin HS; Chao JC; Chien YW; Peng HC; Chen JR J Nutr Biochem; 2012 Jun; 23(6):679-84. PubMed ID: 21813270 [TBL] [Abstract][Full Text] [Related]
27. Ethanol metabolism by alcohol dehydrogenase or cytochrome P Doody EE; Groebner JL; Walker JR; Frizol BM; Tuma DJ; Fernandez DJ; Tuma PL Am J Physiol Gastrointest Liver Physiol; 2017 Dec; 313(6):G558-G569. PubMed ID: 28864499 [TBL] [Abstract][Full Text] [Related]
28. Bik/NBK accumulation correlates with apoptosis-induction by bortezomib (PS-341, Velcade) and other proteasome inhibitors. Zhu H; Zhang L; Dong F; Guo W; Wu S; Teraishi F; Davis JJ; Chiao PJ; Fang B Oncogene; 2005 Jul; 24(31):4993-9. PubMed ID: 15824729 [TBL] [Abstract][Full Text] [Related]
29. Dynamics of cytochrome P4502E1 activity in man: induction by ethanol and disappearance during withdrawal phase. Oneta CM; Lieber CS; Li J; Rüttimann S; Schmid B; Lattmann J; Rosman AS; Seitz HK J Hepatol; 2002 Jan; 36(1):47-52. PubMed ID: 11804663 [TBL] [Abstract][Full Text] [Related]
30. Protective Effects of Taraxasterol against Ethanol-Induced Liver Injury by Regulating CYP2E1/Nrf2/HO-1 and NF- Xu L; Yu Y; Sang R; Li J; Ge B; Zhang X Oxid Med Cell Longev; 2018; 2018():8284107. PubMed ID: 30344887 [TBL] [Abstract][Full Text] [Related]
31. Ethanol and arachidonic acid produce toxicity in hepatocytes from pyrazole-treated rats with high levels of CYP2E1. Wu D; Cederbaum AI Mol Cell Biochem; 2000 Jan; 204(1-2):157-67. PubMed ID: 10718635 [TBL] [Abstract][Full Text] [Related]
32. Relationship between cytochrome P450 catalytic cycling and stability: fast degradation of ethanol-inducible cytochrome P450 2E1 (CYP2E1) in hepatoma cells is abolished by inactivation of its electron donor NADPH-cytochrome P450 reductase. Zhukov A; Ingelman-Sundberg M Biochem J; 1999 Jun; 340 ( Pt 2)(Pt 2):453-8. PubMed ID: 10333489 [TBL] [Abstract][Full Text] [Related]
34. Induction mechanisms of cytochrome P450 2E1 in liver: interplay between ethanol treatment and starvation. Hu Y; Ingelman-Sundberg M; Lindros KO Biochem Pharmacol; 1995 Jul; 50(2):155-61. PubMed ID: 7632158 [TBL] [Abstract][Full Text] [Related]
35. Activity probe for in vivo profiling of the specificity of proteasome inhibitor bortezomib. Berkers CR; Verdoes M; Lichtman E; Fiebiger E; Kessler BM; Anderson KC; Ploegh HL; Ovaa H; Galardy PJ Nat Methods; 2005 May; 2(5):357-62. PubMed ID: 15846363 [TBL] [Abstract][Full Text] [Related]
36. Proteasome inhibitor PS-341 causes cell growth arrest and apoptosis in human glioblastoma multiforme (GBM). Yin D; Zhou H; Kumagai T; Liu G; Ong JM; Black KL; Koeffler HP Oncogene; 2005 Jan; 24(3):344-54. PubMed ID: 15531918 [TBL] [Abstract][Full Text] [Related]
37. Hyperphosphorylation of rat liver proteasome subunits: the effects of ethanol and okadaic acid are compared. Bardag-Gorce F; Venkatesh R; Li J; French BA; French SW Life Sci; 2004 Jun; 75(5):585-97. PubMed ID: 15158368 [TBL] [Abstract][Full Text] [Related]
38. Evidence for cytochrome P450 2E1 catalytic activity and expression in rat blood lymphocytes. Dey A; Dhawan A; Kishore Seth P; Parmar D Life Sci; 2005 Jul; 77(10):1082-93. PubMed ID: 15890371 [TBL] [Abstract][Full Text] [Related]
39. Peptidase activities of the multicatalytic protease in rat liver after voluntary and intragastric ethanol administration. Donohue TM; Zetterman RK; Zhang-Gouillon ZQ; French SW Hepatology; 1998 Aug; 28(2):486-91. PubMed ID: 9696015 [TBL] [Abstract][Full Text] [Related]
40. Investigation of drug-drug interaction potential of bortezomib in vivo in female Sprague-Dawley rats and in vitro in human liver microsomes. Lu C; Gallegos R; Li P; Xia CQ; Pusalkar S; Uttamsingh V; Nix D; Miwa GT; Gan LS Drug Metab Dispos; 2006 Apr; 34(4):702-8. PubMed ID: 16443666 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]